Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 150 followers
Latest posts
Last updated 1 day ago
Highlight report from the sixth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines
1 day ago
Highlight report from the sixth meeting of the industry stakeholder platform on...
Call for expressions of interest for civil society representatives to participate in work of Committee for Advanced Therapies
1 day ago
Call for expressions of interest for civil society representatives to participate in...
Orphan designation: velaglucerase alfa, Treatment of Gaucher disease, 06/06/2010, Positive
1 day ago
Orphan designation: velaglucerase alfa, Treatment of Gaucher disease, 06/06/2010, Positive
Orphan designation: Recombinant human parathyroid hormone, Treatment of hypoparathyroidism, 16/01/2014, Positive
1 day ago
Orphan designation: Recombinant human parathyroid hormone, Treatment of hypoparathyroidism, 16/01/2014, Positive
Orphan designation: Maralixibat chloride, Treatment of biliary atresia, 27/07/2020, Positive
1 day ago
Orphan designation: Maralixibat chloride, Treatment of biliary atresia, 27/07/2020, Positive
Orphan designation: (4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5- tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride (maralixibat chloride), Treatment of primary scler
1 day ago
Orphan designation: (4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5- tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride (maralixibat chloride), Treatment of primary sclerosing cholangitis...
Orphan designation: (4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5- tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride (maralixibat chloride), Treatment of primary bilia
1 day ago
Orphan designation: (4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5- tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride (maralixibat chloride), Treatment of primary biliary cirrhosis...
Orphan designation: (4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5- tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride (maralixibat chloride), Treatment of Alagille synd
1 day ago
Orphan designation: (4R,5R)-1-[[4-[[4-[3,3-dibutyl-7-(dimethylamino)-2,3,4,5- tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octane chloride (maralixibat chloride), Treatment of Alagille syndrome, 16/01/2014...
Sixth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, from 30/06/2021 to 30/06/2021
1 day ago
Sixth meeting of the industry stakeholder platform on the operation of the...
Veterinary medicines European public assessment report (EPAR): Enteroporc Coli AC, Neonatal piglet colibacillosis (recombinant, inactivated),Clostridium perfringens vaccine (inactivated), Date of authorisation: 09/12/2020, Revision: 1, Status: Authorised
1 day ago
Veterinary medicines European public assessment report (EPAR): Enteroporc Coli AC, Neonatal piglet...
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia;Alzheimer Disease;Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 12, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia;Alzheimer Disease;Parkinson...
Human medicines European public assessment report (EPAR): Byetta, exenatide, Diabetes Mellitus, Type 2, Date of authorisation: 20/11/2006, Revision: 26, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Byetta, exenatide, Diabetes Mellitus, Type...